CARLEE CLARINO: Open Payments
NPI 1629744586 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 26 payments from 9 companies in 2025. Trend: 2023 $255 · 2024 $131 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $154 |
| Astellas Pharma US Inc | 5 | $131 |
| AstraZeneca Pharmaceuticals LP | 5 | $121 |
| ABBVIE INC. | 2 | $48 |
| Lilly USA, LLC | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| PFIZER INC. | 1 | $18 |
Products named: Veozah, Wegovy, BREZTRI, VRAYLAR, MOUNJARO, AIRSUPRA, NUCALA, XIFAXAN.
Industry payments across CT — which companies pay providers there.
